Ken Griffin’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,213
| Closed | -$102K | – | 6254 |
|
|
2025
Q1 | $102K | Sell |
3,213
-591
| -16% | -$18.8K | ﹤0.01% | 5143 |
|
|
2024
Q4 | $148K | Buy |
+3,804
| New | +$148K | ﹤0.01% | 5019 |
|
|
2024
Q2 | – | Sell |
-4,016
| Closed | -$183K | – | 6261 |
|
|
2024
Q1 | $183K | Buy |
+4,016
| New | +$183K | ﹤0.01% | 4830 |
|
|
2023
Q1 | – | Sell |
-3,518
| Closed | -$178K | – | 6157 |
|
|
2022
Q4 | $178K | Buy |
+3,518
| New | +$178K | ﹤0.01% | 4762 |
|
|
2022
Q1 | – | Sell |
-4,860
| Closed | -$386K | – | 6653 |
|
|
2021
Q4 | $386K | Sell |
4,860
-1,657
| -25% | -$132K | ﹤0.01% | 4853 |
|
|
2021
Q3 | $580K | Buy |
6,517
+2,598
| +66% | +$231K | ﹤0.01% | 4375 |
|
|
2021
Q2 | $390K | Buy |
+3,919
| New | +$390K | ﹤0.01% | 4953 |
|
|
2021
Q1 | – | Sell |
-5,368
| Closed | -$509K | – | 6460 |
|
|
2020
Q4 | $509K | Buy |
+5,368
| New | +$509K | ﹤0.01% | 3840 |
|
|
2020
Q3 | – | Sell |
-7,957
| Closed | -$559K | – | 4890 |
|
|
2020
Q2 | $559K | Buy |
+7,957
| New | +$559K | ﹤0.01% | 3367 |
|